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© 2010 The Japan Society of Histochemistry and Cy- Cadherins are a family of transmembrane glycoproteins that mediate cell-to-cell adhesion.
A change in cadherin type in cells, i.e., cadherin switching, induces changes in the character
of the cell. Recent studies of the developing rat adenohypophysis found that primordial cells
co-expressed E- and N-cadherins, but that hormone-producing cells lost E-cadherin and ul-
timately possessed only N-cadherin. In the present study, we examined the roles of cadherin
switching in cytogenesis of anterior pituitary cells by observing prolactin mRNA and protein
expression in lactotrophs that were transformed with an E-cadherin expression vector.
In hormone-producing cells that were transfected with a pIRES2-ZsGreen1 plasmid with a
full-length E-cadherin cDNA (rE-cad-IZ) insert in primary culture, we detected E- and N-
cadherins on plasma membrane and E-cadherin in cytoplasm. In these rE-cad-IZ-transfected
cells,  in situ hybridization revealed prolactin mRNA signals that were at a level identical
to that in control cells, while prolactin protein was barely detectable using immuno-
cytochemistry. The mean signal intensity of prolactin protein in rE-cad-IZ-transfected cells
was approximately one fourth that in intact cells and in null-IZ-transfected cells (P<0.01).
These results suggest that the expression of E-cadherin does not affect prolactin mRNA
transcription; rather, it reduces prolactin protein content, presumably by affecting trafficking
of secretory granules.
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I. Introduction
Cadherins are a large family of transmembrane glyco-
proteins that mediate specific cell-to-cell adhesion in a
Ca2+-dependent manner [23]. There are many types of
cadherin, including E-cadherin, which is expressed mainly
in epithelial tissues, and N-cadherin, which is expressed in
neural tissues [23]. Each cadherin associates in a homophilic
manner to promote specific cell-to-cell adhesion [11].
Recently, it has been suggested that cadherin initiates signal
transduction through catenins, which bind to the cadherin
cytoplasmic domain [11, 15, 19].
It has been reported that the cadherin type in cells
changes during neural tube formation, optic cap formation,
and emigration of neural crest cells [17, 20, 26]. This change
is referred as cadherin switching [25]. Many studies have
shown that cadherin switching alters the character of cells.
One representative example of this phenomenon is the
epithelial-to-mesenchymal transition of cells, in which the
cadherin type switches from E- to N-cadherin [4, 25].
In the pituitary gland, it was reported that hormone-
producing cells express N-cadherin [8, 24]. In addition,
Kikuchi et al. reported that cells in the adenohypophyseal
placode co-expressed both E- and N-cadherin, and that
hormone-producing cells lost expression of E-cadherin
during cell differentiation [9, 10]. In addition, there appeared
to be a close relation between cadherin switching and theKusumoto et al. 84
onset of hormone synthesis or accumulation [9, 10]. These
findings suggest that an investigation of the experimental
expression of E-cadherin in mature hormone-producing
cells might increase our understanding of the roles of
cadherin switching in the cytogenesis of anterior pituitary
cells.
Hormone secretion in the anterior pituitary gland is
regulated by a variety of humoral factors, i.e., by hypo-
thalamic hormones, gonadal hormones, thyroid hormones,
and certain growth factors [3, 14]. It is generally known
that prolactin secretion is negatively regulated by dopamine
in vivo. However, under in vitro conditions, prolactin secre-
tion increases in the absence of stimulation, as it is no longer
strongly inhibited by dopamine [1]. Using in situ hybridiza-
tion and immunocytochemical techniques, we utilized lac-
totrophs to examine whether forced E-cadherin expression
by gene transfection affects prolactin mRNA expression and
prolactin production.
II. Materials and Methods
Animals
Male Sprague-Dawley rats (Japan SLC, Shizuoka,
Japan) and male transgenic S100b-GFP rats [6] that express
green fluorescent protein under the promoter control of the
S100 beta protein gene, a marker of folliculo-stellate cells,
were used (age, 8–10 weeks; weight, 250–300 g). The
S100b-GFP rats were bred in our laboratory. All rats were
given ad libitum access to food and water and kept under a
light cycle of 12 hr light and 12 hr darkness. All animals
were treated in accordance with the Guidelines for Animal
Experimentation of Jichi Medical University, which are
based on the NIH Guidelines for the Care and Use of
Laboratory Animals.
Primary culture
Rats were perfused with Ca2+- and Mg2+-free (CMF)
Hanks’ solution through the left ventricle and bled from
the right atrium under deep Nembutal anesthesia. Anterior
pituitary glands were excised and cells were dispersed as
described in Kikuchi et al. [8]. Dispersed cells were re-
suspended in Medium 199 (Invitrogen, Carlsbad, CA, USA)
supplemented with 10% fetal bovine serum (Sigma Aldrich,
St. Louis, MO, USA), 100 u/ml penicillin, and 100 µg/ml
streptomycin (Invitrogen), plated on 8-well glass chamber
slides (0.8 cm2/well; Nalge Nunc International, Rochester,
NY, USA) at a density of 1×105 cells/400 µl/cm2, and cul-
tured at 37°C in a humidified atmosphere of 5% CO2 and
95% air.
Transfection
Complimentary DNA was synthesized using the total
RNA fraction from anterior pituitaries of male SD rats, and
PCR was performed to amplify the DNA encoding the entire
rat E-cadherin (NM 031334) using specific oligonucleotide
primers with extension of the XhoI and KpnI sites to the 3'
terminals (forward, 5'-GCT CGA GTG TTT GCT CGG
CGT TTG C-3'; reverse, 5'-CCA TGG ATC CAC ACA
GGA ACG ACT C-3'). After purification, the specific PCR
product was digested by XhoI (Takara, Shiga, Japan) and
KpnI (Takara), ligated with pIRES2-ZsGreen1 plasmid
(Clontech, Mountain View, CA, USA), and cloned. The
recombinant plasmid is referred to as rE-cad-IZ.
Anterior pituitary cells were cultured for 2 days as
described above and then transfected with the rE-cad-IZ
plasmid using Lipofectamine 2000 (Invitrogen), as per the
instructions provided by the manufacturer. As a control, a
pIRES2-ZsGreen1 plasmid with null insert (null-IZ) was
used. Cells were cultured for 48 hr after the transfection
procedure and utilized for analysis.
Immunocytochemistry
Culture cells were rinsed with Hanks’ solution and
fixed with 4% paraformaldehyde in 25 mM phosphate buffer
(pH 7.4) for 30 min at room temperature. After immersion in
PBS containing 2% normal goat serum for 30 min at room
temperature, cells were incubated in PBS with monoclonal
antibody against E-cadherin (dilution of 1:1000, BD Bio-
sciences, San Jose, CA, USA) and polyclonal antibody
against N-cadherin (dilution of 1:100, IBL, Gunma, Japan)
overnight at 30°C. After washing with PBS, cells were incu-
bated in PBS with anti-rabbit IgG conjugated with Alexa
568 (Invitrogen) and anti-mouse IgG conjugated with Alexa
633 (Invitrogen) for 30 min at 30°C. Cells were observed
through a confocal laser microscope (FV1000; Olympus,
Tokyo, Japan).
In situ hybridization
In situ hybridization was performed as described in
Fujiwara et al. [5]. The complementary DNA fragment for
the rat prolactin mRNA (NM 012629) was amplified from
rat cDNA by PCR using specific oligonucleotide primers
(forward, 5'-TGC AGA TGA GAA AGC AGT GG-3';
reverse, 5'-TTC AGG ATA GGC CTG GCT AA-3'). The
amplified cDNA fragment was ligated into the pGEM-T
easy vector (Promega, Madison, WI, USA) and cloned.
Antisense and sense digoxigenin (DIG)-labeled cRNA
probes were synthesized using the Roche DIG RNA labeling
kit (Roche Diagnostics, Penzberg, Germany).
Primary culture cells were treated with 4% paraform-
aldehyde in 25 mM phosphate buffer (pH 7.4) for 15 min,
with 0.125 µg/ml proteinase K (Invitrogen) for 1 min, and
with 4% paraformaldehyde for 10 min at room temperature.
Hybridization was performed in a solution containing
50% formamide, 10% dextran sulfate (Wako Pure Chemical
Industries, Osaka, Japan), 3× saline-sodium citrate, 120 mM
phosphate buffer (pH 7.4), 1× Denhardt’s solution (Nacalai
Tesque, Kyoto, Japan), 125 µg/ml tRNA (Invitrogen), and
100 µg/ml sonicated sperm DNA (Invitrogen) overnight at
45°C. After hybridization, the RNA probe was washed in
2× SSC with 50% formamide at 45°C, and incubated in
PBS with monoclonal antibody against digoxigenin (Roche)
overnight at 4°C. After washing with PBS, cells were incu-
bated in PBS with anti-rabbit prolactin antibody (ChemiconEffect of E-cadherin Expression in Lactotrophs 85
International, Temecula, CA, USA) for 90 min at 30°C,
then in PBS with anti-rabbit IgG conjugated with Alexa 568
(Invitrogen) and anti-mouse IgG conjugated with Alexa 633
(Invitrogen) for 30 min at 30°C. Cells were observed
through a confocal laser microscope (FV1000; Olympus,
Tokyo, Japan). MetaMorph software (Molecular Devices,
Downingtown, PA, USA) was used to quantify signal inten-
sities on immunocytochemistry and in situ hybridization.
III. Results
Forced expression of E-cadherin in hormone-producing cells 
in the anterior pituitary of adult rats
Transfected cells were identified with fluorescence
derived from the ZsGreen1 plasmid, as shown in Figure 1
(indicated by arrows and arrowheads). The transfection
rate was usually 2 to 3% and no difference in the rate
was observed among cell types. The transfected cells did not
differ in shape on differential interference contrast images
(Fig. 1A and 1B). We detected N-cadherin on the plasma
membrane (Fig. 1D and 1F) and E-cadherin both on the
plasma membrane and in the cytoplasm of all cells trans-
fected with the rE-cad-IZ plasmid (indicated by arrows in
Fig. 1D, 1F, and 1H). In contrast, we detected only N-
cadherin on the plasma membrane of cells transfected with
the null-IZ plasmid (indicated by arrowheads in Fig. 1C, 1E,
and 1G). These results are not sufficient to confirm that
E-cadherin was successfully induced in hormone-producing
cells, because rE-cad-IZ transfection of non-hormone-
producing folliculo-stellate cells, which express both E- and
N-cadherin [8], may yield similar results. Thus, to confirm
forced E-cadherin expression in hormone-producing cells,
we transfected purified hormone-producing cells with rE-
cad-IZ. Hormone-producing cells were purified from trans-
genic S100b-GFP rat anterior pituitary cells [6] by means of
fluorescence-activated cell sorting. Transfected hormone-
producing cells did not differ in cell shape on differential in-
terference contrast images (Fig. 1I and 1J). E-cadherin was
detected on the plasma membrane of rE-cad-IZ-transfected
cells (indicated by the small arrow in Fig. 1J) and in the
Fig. 1. Immunohistochemistry of E-cadherin and N-cadherin in
transformed anterior pituitary cells. Anterior pituitary cells were
transfected with pIRES2-ZsGreen1 plasmid with a null-insert, null-
IZ (A, C, E and G, in the identical field), and the same plasmid
with cDNA for the entire region of rat E-cadherin, rE-cad-IZ (B, D,
F and H, in the identical field). A and B: Differential interference
contrast images of transformed cells. C and D: Merged images of
immunocytochemistry for E-cadherin (light blue), N-cadherin
(red), and fluorescence from ZsGreen1 (green). E and F: Immuno-
reaction of N-cadherin. G and H: Immunoreaction of E-cadherin.
Immunocytochemistry for E-cadherin and a phase-contrast image
of transfected hormone-producing cells sorted by fluorescence-
activated cell sorting are also shown in I and J.  I: Purified
hormone-producing cells were transfected with null-IZ. J: Purified
hormone-producing cells were transfected with rE-cad-IZ. The
differential interference contrast image is merged. The differential
interference contrast image is merged. Arrows and arrowheads indi-
cate cells transfected with rE-cad-IZ and null-IZ, respectively. A
small arrow shows the boundary of cells transfected with rE-cad-IZ.
Bar=5 µm.Kusumoto et al. 86
cytoplasm of hormone-producing cells. However, we did not
detect E-cadherin in null-IZ-transfected hormone-producing
cells (Fig. 1I).
Prolactin immunoreactivities and mRNA signals in 
hormone-producing cells expressing E-cadherin
We detected prolactin immunoreactivity and mRNA
signals in primary culture by means of immunocytochemical
and in situ hybridization techniques. In intact cells, obvious
prolactin immunoreactivity (Fig. 2C, 2D, 2E, and 2F) and
mRNA signals (Fig. 2C, 2D, 2G and 2H) were obvious. In
null-IZ-transfected cells (indicated by the arrowheads in Fig.
2), prolactin immunoreactivity and mRNA signals (Fig. 2C,
2E and 2G) were identical to those detected in intact cells.
In contrast, in rE-cad-IZ-transfected cells (indicated by the
arrows in Fig. 2), prolactin mRNA signals (Fig. 2D and 2H)
were detected, but prolactin immunoreactivity (Fig. 2C and
2F) was barely detectable.
To confirm that prolactin immunoreactivity was sup-
pressed in rE-cad-IZ-transfected cells, we classified pro-
lactin mRNA signal intensities and prolactin immuno-
reactivity. As shown in the Table, all cells in the intact group
and null-IZ-transfected group displayed strong immuno-
reactivity. In the rE-cad-IZ-transfected group, there was no
evidence of strong immunoreactivity, i.e., all cells showed
weak or no immunoreactivity (Table 1). Next, we used
MetaMorph software to quantify the fluorescence intensity
on immunocytochemistry and in situ hybridization (Fig. 3).
The mean signal intensity of prolactin protein in rE-cad-IZ-
transfected cells was approximately 25% of that of intact
cells and null-IZ-transfected cells. In contrast, the mean
signal intensity of prolactin mRNA signals in rE-cad-IZ-
transfected cells did not differ from that of intact cells and
null-IZ-transfected cells.
IV. Discussion
This is the first report to show forced expression of
E-cadherin in rat anterior pituitary cells and its effects on
hormone production. Using immunocytochemical tech-
niques, we detected exogenous E-cadherin on hormone-
producing cells. Exogenous E-cadherin and endogenous
N-cadherin were successfully detected on the plasma
membrane of hormone-producing cells that were transfected
with rE-cad-IZ (Fig. 1D, 1F, 1H, and 1J). In contrast, we de-
tected only N-cadherin in null-IZ-transfected cells (Fig. 1C,
1E, and 1G). These results suggest that E-cadherin derived
from a transferred gene can be transported to the plasma
membrane in hormone-producing cells.
The level of prolactin mRNA expression in rE-cad-IZ-
transfected cells appeared similar to that in untransfected
cells and null-IZ-transfected cells (Figs. 2 and 3). However,
the immunoreactivity of prolactin in rE-cad-IZ-transfected
cells was significantly lower than in untransfected cells and
null-IZ-transfected cells (Figs. 2 and 3). These results show
that exogenous E-cadherin does not affect prolactin mRNA
transcription; rather, it decreases the protein content of pro-
lactin. These conflicting results indicate that the reduction in
prolactin protein results from inhibition of prolactin protein
synthesis, acceleration of prolactin release, or enhancement
Fig. 2. In situ hybridization and immunocytochemistry of trans-
fected anterior pituitary cells. Anterior pituitary cells in primary
culture were transfected with null-IZ (A, C, E and G, in the identi-
cal field) and with rE-cad-IZ (B, D, F and H, in the identical field).
A and B: Differential interference contrast images of transformed
cells. C and D: Merged images of immunoreaction of prolactin
protein (red), in situ hybridization signal for prolactin mRNA
(light blue), and fluorescence from ZsGreen1 (C and D). E and F:
Immunoreaction of prolactin. G and H:  In situ hybridization
signals for prolactin mRNA. Arrows and arrowheads show cells
transfected with rE-cad-IZ and null-IZ, respectively. Bar=5 µm.Effect of E-cadherin Expression in Lactotrophs 87
of prolactin digestion in the rE-cad-IZ-transfected lacto-
trophs. It is unlikely that E-cadherin expression inhibited
translation, which leaves two possibilities.
Firstly, digestion of secretory granules in E-cadherin-
expressing lactotrophs may have been accelerated. It has
been reported that nascent E-cadherin binds to catenin com-
plex to expedite transport from the Golgi network to the
plasma membrane [13]. In addition, it was reported that E-
cadherin that had not bound to catenin complex was not
transported to the plasma membrane, but was instead de-
graded in lysosomes [16]. As shown in Figure 1, exogenous
E-cadherin was detected in cytoplasm, which suggests that
the catenin complex present was insufficient for the amount
of E-cadherin that had been overexpressed. If E-cadherin is
located on hormone secretory granules, as is the case in
pancreatic beta cells [2], the granules with E-cadherin not
bound to catenin would be transported to lysosomes for
degradation. Although this process may indeed explain the
decreased prolactin content in transfected lactotrophs, we
believe the next hypothesis is more likely.
One of the most important effects of E-cadherin ex-
pression on cell phenotype appears on cytoskeletal fibers.
Cytoskeletal fibers are anchored to E-cadherin on the plasma
membrane through catenin [19] and the amount of E-
cadherin is reported to possess a close relation with the
amount of cytoskeletal fibers [22]. In pancreatic beta cells,
it has been shown that destabilization of F-actin affects
insulin secretion both positively [18] and negatively [12].
E-cadherin is also reported to enhance the activity of mo-
tor proteins of the myosin family [7, 22]. Thus, factitious
expression of E-cadherin would alter cytoskeletal structure
of lactotrophs, and the change could accelerate trafficking
of secretory granules, which may be another reason for the
decreased prolactin content in transfected lactotrophs.
Many studies have reported changes in gene expression
after cadherin switching [4, 25]. However, the differences in
downstream signal transduction between E- and N-cadherin
have yet to be clarified. Seidel et al. reported that a type of
p120 catenin, which binds to the intracellular domain of
each cadherin, differs between E- and N-cadherin [21]. Un-
fortunately, at present it is difficult to describe the molecular
mechanisms that cause the changes in gene expression
which underlie cadherin switching. The present study has
shown that forced E-cadherin expression in lactotrophs of
adult rats significantly reduced prolactin content. We are in-
clined to conclude that this result is linked to the observation
that E-cadherin expression is lost in hormone-producing
cells at the onset of hormone production in the developing
adenohypophysis [9].
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